In this article:

Medicine Man Technologies (SHWZ) Gets a Buy Rating from Noble Financial

In this article:
In this article:

Noble Financial analyst Joe Gomes maintained a Buy rating on Medicine Man Technologies (SHWZResearch Report) today and set a price target of $4.00. The company’s shares closed last Friday at $1.98.

According to TipRanks.com, Gomes is a 5-star analyst with an average return of 18.9% and a 46.1% success rate. Gomes covers the Technology sector, focusing on stocks such as Comtech Telecommunications, Voyager Digital (Canada), and One Stop Systems.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Medicine Man Technologies with a $4.00 average price target.

See Insiders’ Hot Stocks on TipRanks >>

The company has a one-year high of $3.25 and a one-year low of $1.16. Currently, Medicine Man Technologies has an average volume of 55.04K.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Medicine Man Technologies, Inc. engages in the cultivation, marketing, and distribution of medical and recreational cannabis. It provides supply chain, cultivation, dispensary, processing, and feasibility consulting. The company was founded by Andrew Williams on March 20, 2014 and is headquartered in Denver, CO.

Read More on SHWZ:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More

Latest News Feed

In this article:

Latest News Feed